Emmanuel Antonarakis, Clark Endowed Professor of Medicine at Masonic Cancer Center, University of Minnesota, shared on X about a recent paper by Mayuko Kanayama et al. published in Nature:
“A novel west-African germline founder mutation in HOXB13 (p.X285Kext) increases risk of high-grade prostate cancer but also enhances sensitivity to hormonal therapy. Congrats to PCF-funded Mayuko Kanayama”
Title: Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant
Authors: Mayuko Kanayama, Emeline Colomba, Yusra Shao, Sarah M. Nielsen, Edward D. Esplin, Changxue Lu, William B. Isaacs, John C. Henegan, Elisabeth I. Heath, Jun Luo, Régine Marlin and Emmanuel S. Antonarakis
More posts featuring Emmanuel Antonarakis on OncoDaily.
